In this webinar Nick Lench, PhD, Chief Scientific Officer at Congenica reviews the current state of knowledge regarding the genetics of COVID-19 and the potential application of pharmacogenetics to patient management and clinical trials. Dr Lench also describe the development of a Congenica COVID-19 application that enables the analysis of a patient’s genome data to identify clinically actionable DNA variants.

Learn more about the Congenica platform: [ Ссылка ]
Get in touch to learn more about our COVID-19 module: [ Ссылка ]

свернуть